Darren Verlenden new CEO of Single Use Support

michael-muehlegger

Michael Mühlegger

December 16, 2024

Table of contents

Show

Single Use Support Announces Darren Verlenden as CEO and Strengthens Leadership Team for Further Growth and Global Expansion.

Single Use Support, a leading provider of innovative fluid management and cold chain solutions for the biopharmaceutical industry, is pleased to announce the appointment of Darren Verlenden as Chief Executive Officer, effective immediately. This strategic move, along with key additions to the leadership team, underscores the company's commitment to driving forward its ambitious global growth plans.

Prior to this appointment Darren was the Executive Vice President for the Process Solutions business of Merck KGaA Darmstadt Germany.  He brings 20+ years of knowledge and expertise to the company, through his extensive experience in the Life Science manufacturing sector.

In his new role, Darren will be responsible for driving the growth strategy and expansion of Single Use Support's global commercial and operational footprint. "I am excited to join such a talented team and help Single Use Support embark on the next phase of its growth trajectory” said Verlenden. “The portfolio has exceptional differentiated value, and a strong history of delivering innovative solutions that meet the evolving needs of our clients."

Darren Verlenden_CEO_Single Use Support-1

Managing Director Christian Praxmarer is confident that Darren will leverage his expertise to strengthen the company’s market position: “His commercial leadership and strategic development skills will be invaluable in deepening Single Use Support's commitment to quality and innovation.”  Christian will continue to be an instrumental part of the Single Use Support leadership team in his role as Chief Operating Officer, based in Kufstein.

Johan Hueffer, Senior Partner, Principal Investments at Novo Holdings said, “We are delighted to welcome Darren to the Single Use Support team. He is a dynamic global leader with highly relevant experience, and an excellent fit to the Single Use Support organization. We look forward to working with him to continue to grow the business and deliver long-term value for our customers and shareholders.”

Further key additions to the team and advisory board

In addition to the CEO appointment Single Use Support has continued to strengthen its executive team with the recent hire of industry veteran Ulrike Lemke as Chief Commercial Officer. Ulrike has previously held senior positions in commercial and manufacturing operations at Lonza, Sartorius and most recently Recipharm. Both key leadership appointments are designed to accelerate the global presence of Single Use Support as a key player in the life sciences sector.

ULLE-2

In addition, two senior independent directors have joined the Advisory Board of Single Use Support.

Meeta Gulyani, with extensive experience spanning commercial, strategy and M&A across Pharmaceutical and Life Science industries, including Sanofi, Roche, Merck KGaA and recently appointed as Head of Life Science Strategy and General Manager – Bioprocessing at Ecolab, will contribute her tremendous expertise and connectivity in the space.

Stefan Stoffel, formerly Chief Operating Officer at Lonza, brings vast knowledge and decades of experience of operations and manufacturing excellence in the bioprocessing industry.

With the completion of its top management and broadening of the Advisory Board, Single Use Support is now well positioned to take the next step in its success story as it collaborates with biopharmaceutical clients to achieve quality outcomes.

michael-muehlegger

Michael Mühlegger

Senior Director Marketing & Inside Sales

Michael Mühlegger is the Head of Marketing and Inside Sales at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

 

More from Michael Mühlegger

mRNA & LNPs.

Oligonucleotide manufacturing – challenges & solutions

Oligonucleotide manufacturing. Optimizing fluid management, freezing & cold storage | Purification Oligonucleotides

michael-muehlegger

Michael Mühlegger

October 25, 2024

mRNA & LNPs.

Oligonucleotides simply explained

What are oligonucleotides? Nucleic acid types | RNA oligonucleotides | DNA oligos | Types of Oligonucleotides

michael-muehlegger

Michael Mühlegger

October 25, 2024

Read more about News

News

Single Use Support honoured as one of the ‘Best Managed Companies’

Deloitte Austria and Raiffeisenlandesbank Niederösterreich-Wien have honoured outstandingly managed companies. Single Use Support was the only winner from Tyrol to be honoured with the title ‘Best Managed Company 2024’. 

micheal-eder

Michael Eder

September 30, 2024

News

Novo Holdings Acquires Majority Stake in Single Use Support

The Danish company Novo Holdings has acquired a 60% majority stake in the Austrian-based company Single Use Support, thereby strengthening the company's further growth on a global level.

michael-muehlegger

Michael Mühlegger

May 14, 2024

News

Sustainability Report: Commitment to Protecting Life and the Environment

Discover Single Use Supports sustainability goals, social impact, environmental impact, and industry impact in the fluid and cold chain management as part of the biopharmaceutical industry.

Armin Lassl - Single Use Support

Armin Lassl

April 29, 2024

News

Single Use Support in the midst of change in the healthcare industry

In the wake of the pandemic, the biotech industry is in a state of upheaval: more and more new drugs are being developed and produced. The Tyrolean company Single Use Support is actively involved in this process and continues to grow.

micheal-eder

Michael Eder

September 21, 2023